After struggling for more than 20 years to develop cancer drugs without success, West Lafayette-based Endocyte Inc. is pausing it own R&D efforts to concentrate on a potential blockbuster drug from a German chemical company.
The appointments mark the latest changes in the Indianapolis-based drugmaker’s executive suite since David Ricks took over as CEO in January.
U.S. regulators have approved a new medicine for treating a common type of breast cancer after it has spread to other parts of the body.
From January to July, the agency sent 265 warning letters to companies, notifying them of what it alleged to be serious violations of federal rules. That’s the lowest tally for the first seven months of any year since 2008.
Castlight Health, a benefits platform, estimates that opioid abusers cost employers nearly twice as much in health-care expenses as their clean co-workers—an extra $8,600 a year.
Unfortunately, what started as a solution for pain turned into a crisis that is killing people.
A sampling of panelists’ conversation at IBJ’s Sept. 21 Health Care & Benefits Power Breakfast.
Hoosiers buying health insurance on the Obamacare marketplace will pay an average of nearly $500 a month in premiums next year, a sharp rise over current rates.
In a quest to end cookie-cutter health care, U.S. researchers are getting ready to recruit more than 1 million people for an unprecedented study to learn how our genes, environments and lifestyles interact—and to finally customize ways to prevent and treat disease. Why does one sibling get sick but not another? Why does a drug […]
Researchers at Indiana University and Purdue University have received $2.55 million from Susan G. Komen to study possible new treatments.
The panel will help promote collaboration among treatment providers, criminal justice systems and child welfare agencies.
St. Vincent Health filed an application Sept. 22 with the state, seeking to remodel 192,327 square feet of the Parkwood West Building, 250 West 96th St., for administrative offices.
The National Business Group on Health is projecting the total cost of providing medical and pharmacy benefits to increase 5 percent for the fifth consecutive year in 2018.
Senate Republicans, short of votes, abandoned their latest and possibly final attempt to kill the health care law Tuesday, just ahead of a critical end-of-the-week deadline.
Health experts at an IBJ Health Care & Benefits panel discussion on Thursday said passage of the Graham-Cassidy bill could challenge Indiana's ability to care for low-income Hoosiers.
Indiana Gov. Eric Holcomb has joined 14 other Republican governors in backing a last-ditch GOP effort to repeal former President Barack Obama's signature health care law.
Dr. Kristina Box will take over Indiana’s top health job next month, succeeding Dr. Jerome Adams, who resigned to become U.S. surgeon general.
The agreement calls for the housing authority in the central Indiana community to compensate seven victims of discrimination identified by the U.S. Department of Justice.
The Greenfield-based unit, which makes a vast array of vaccines, antibiotics, feed additives and other health products for livestock and pets, is in a slump, after more than a decade of growth.
li Lilly and Co.’s experimental breast cancer drug abemaciclib, when combined with standard therapy, slowed the progression of tumors in patients with an advanced form of the disease.
